Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2008

View Archived Issues

Stanford University identifies two potential drug targets to treat malaria

Transcutaneous immunization effective in protecting against enterohemorrhagic E. coli infection

New antiinfective agents described in recent GSK patents

Activation of the unfolded protein response central in the pathogenesis of Charcot-Marie-Tooth 1B

Trophos receives grant to evaluate TRO-19622 in Parkinson's disease

Cogentus appoints Scientific Steering Committee for CGT-2168 phase III clinical program

University of Adelaide awarded AUD 2 million grant for five-year hepatitis C project

Toyama Chemical initiates phase II trial of T-5224 for rheumatoid arthritis

Takeda profiles Q3 developments

Risperidone long-acting injection delays relapse in bipolar disorder

Studies show aripiprazole efficacy in pediatric psychological disorders

Recent patents impart novel therapeutic agents for respiratory disorders

New antiinfective agents reported in recent patents

OctoPlus and Biolex commence phase IIa Locteron study in hepatitis C

MGCD-0103 receives orphan drug designation for acute myelogenous leukemia

Merck KGaA and Novo Nordisk disclose new diabetes compounds in recent patent literature

Pharmacopeia selects novel chemokine receptor antagonist for development

TopoTarget clarifies collaboration with Leo Pharma

Sosei commences AD-923 phase III studies in Europe

Promising interim results reported from phase III Zadaxin trial in hepatitis C

Symbollon Pharmaceuticals completes phase III trial of IoGen for fibrocystic breast disease

Solstice Neurosciences responds to FDA early communication regarding Myobloc for cervical dystonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...